Skip to main content
OpenTrials

Clinical trial condition

Primary Myelofibrosis

Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.

453 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Primary Myelofibrosis trial results

Completed

A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms

NCT01387763

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Dept of Hematology, Aalborg hospital Aalborg, Denmark
  • Dept. of Hematology, Aarhus University Hospital Aarhus, Denmark
  • Dept of Hematology, Rigshospitalet Copenhagen, Denmark
  • Dept of Hematology, Esbjerg Hospital Esbjerg, Denmark
View Trial Details
Completed

Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF

NCT01423851

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
Locations
  • Mayo Clinic Scottsdale Recruiting Scottsdale, Arizona, United States
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • Mayo Clinic, Jacksonville Jacksonville, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View Trial Details
Completed

Study of the Safety of PIM447 in Combination With Ruxolitinib (INC424) and LEE011 in Patients With Myelofibrosis

NCT02370706

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Novartis Investigative Site VIC, Melbourne, Australia
  • Novartis Investigative Site Toronto, Ontario, Canada
  • Novartis Investigative Site Villejuif, France
  • Novartis Investigative Site Mainz, Germany
View Trial Details
Completed

A Phase 2 Study of RO7490677 In Participants With Myelofibrosis

NCT01981850

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Fibrosis, +11 more
Locations
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Emory Hospital Atlanta, Georgia, United States
  • University of Maryland Medical Center Baltimore, Maryland, United States
View all 23 locations
View Trial Details
Completed

Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor

NCT02426086

Conditions
Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +7 more
Locations
  • Birmingham, Alabama, United States
  • Duarte, California, United States
  • La Jolla, California, United States
  • Los Angeles, California, United States
View all 72 locations
View Trial Details

Related conditions